MMSI Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of 8.48% compared to Merit Medical Systems's net margin of 14.45%. Merit Medical Systems's return on equity of 9.19% beat Boston Scientific's return on equity of 9.57%.

Merit Medical Systems has a consensus price target of $107.00, signalling upside risk potential of 15.22%. On the other hand Boston Scientific has an analysts' consensus of $116.12 which suggests that it could grow by 11.53%. Given that Merit Medical Systems has higher upside potential than Boston Scientific, analysts believe Merit Medical Systems is more attractive than Boston Scientific.

Merit Medical Systems has a beta of 0.696, which suggesting that the stock is 30.439% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.685, suggesting its less volatile than the S&P 500 by 31.536%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than Boston Scientific quarterly revenues of $4.7B. Merit Medical Systems's net income of $30.1M is lower than Boston Scientific's net income of $674M. Notably, Merit Medical Systems's price-to-earnings ratio is 45.52x while Boston Scientific's PE ratio is 76.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.02x versus 8.83x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

ICU Medical has a net margin of 8.48% compared to Merit Medical Systems's net margin of -3.78%. Merit Medical Systems's return on equity of 9.19% beat ICU Medical's return on equity of -5.75%.

Merit Medical Systems has a consensus price target of $107.00, signalling upside risk potential of 15.22%. On the other hand ICU Medical has an analysts' consensus of $186.40 which suggests that it could grow by 38.77%. Given that ICU Medical has higher upside potential than Merit Medical Systems, analysts believe ICU Medical is more attractive than Merit Medical Systems.

Merit Medical Systems has a beta of 0.696, which suggesting that the stock is 30.439% less volatile than S&P 500. In comparison ICU Medical has a beta of 0.870, suggesting its less volatile than the S&P 500 by 12.976%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. ICU Medical pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than ICU Medical quarterly revenues of $629.8M. Merit Medical Systems's net income of $30.1M is higher than ICU Medical's net income of -$23.8M. Notably, Merit Medical Systems's price-to-earnings ratio is 45.52x while ICU Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.02x versus 1.38x for ICU Medical. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of 8.48% compared to Merit Medical Systems's net margin of -58.2%. Merit Medical Systems's return on equity of 9.19% beat Masimo's return on equity of -23.05%.

Merit Medical Systems has a consensus price target of $107.00, signalling upside risk potential of 15.22%. On the other hand Masimo has an analysts' consensus of $195.70 which suggests that it could grow by 21.2%. Given that Masimo has higher upside potential than Merit Medical Systems, analysts believe Masimo is more attractive than Merit Medical Systems.

Merit Medical Systems has a beta of 0.696, which suggesting that the stock is 30.439% less volatile than S&P 500. In comparison Masimo has a beta of 1.229, suggesting its more volatile than the S&P 500 by 22.855%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems pays -- of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than Masimo quarterly revenues of $600.7M. Merit Medical Systems's net income of $30.1M is higher than Masimo's net income of -$349.6M. Notably, Merit Medical Systems's price-to-earnings ratio is 45.52x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.02x versus 4.17x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.

ResMed has a net margin of 8.48% compared to Merit Medical Systems's net margin of 28.26%. Merit Medical Systems's return on equity of 9.19% beat ResMed's return on equity of 25.76%.

Merit Medical Systems has a consensus price target of $107.00, signalling upside risk potential of 15.22%. On the other hand ResMed has an analysts' consensus of $264.49 which suggests that it could grow by 9.32%. Given that Merit Medical Systems has higher upside potential than ResMed, analysts believe Merit Medical Systems is more attractive than ResMed.

Merit Medical Systems has a beta of 0.696, which suggesting that the stock is 30.439% less volatile than S&P 500. In comparison ResMed has a beta of 0.783, suggesting its less volatile than the S&P 500 by 21.661%.

Merit Medical Systems has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ResMed offers a yield of 0.86% to investors and pays a quarterly dividend of $0.53 per share. Merit Medical Systems pays -- of its earnings as a dividend. ResMed pays out 27.65% of its earnings as a dividend. ResMed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Merit Medical Systems quarterly revenues are $355.4M, which are smaller than ResMed quarterly revenues of $1.3B. Merit Medical Systems's net income of $30.1M is lower than ResMed's net income of $365M. Notably, Merit Medical Systems's price-to-earnings ratio is 45.52x while ResMed's PE ratio is 27.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems is 4.02x versus 7.11x for ResMed. Usually stocks with elevated PS ratios are considered overvalued.